"Work Is the New Retirement"-Don't Let That Be You

Social Security's failing. Inflation's rising. And retirees are being forced back to work. That's why I created a new strategy: "AI Royalties." Backed by Trump's $500B plan, it's helping Americans collect up to $4,290/month in second retirement income. My short video explains how.

South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs

GERALD IMRAY and MARIA CHENG
November 24, 2023

CAPE TOWN, South Africa (AP) -- South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.

Experts see it as a shift in how such countries deal with pharmaceutical behemoths and say it could trigger more efforts to make lifesaving medicines more widely available.

In the COVID-19 pandemic, rich countries bought most of the world's vaccines early, leaving few shots for poor countries and creating a disparity the World Health Organization called "a catastrophic moral failure."

Now, poorer countries are trying to become more self-reliant "because they've realized after COVID they can't count on anyone else," said Brook Baker, who studies treatment-access issues at Northeastern University.

One of the targets is a drug, bedaquiline, that is used for treating people with drug-resistant versions of tuberculosis. The pills are especially important for South Africa, where TB killed more than 50,000 people in 2021, making it the country's leading cause of death.

In recent months, activists have protested efforts by Johnson & Johnson to protect its patent on the drug. In March, TB patients petitioned the Indian government, calling for cheaper generics; the government ultimately agreed J&J's patent could be broken. Belarus and Ukraine then wrote to J&J, also asking it to drop its patents, but with little response.

In July, J&J's patent on the drug expired in South Africa, but the company had it extended until 2027, enraging activists who accused it of profiteering.

The South African government then began investigating the company's pricing policies. It had been paying about 5,400 rand ($282) per treatment course, more than twice as much as poor countries that got the drug via a global effort called the Stop TB partnership.

In September, about a week after South Africa's probe began, J&J announced that it would drop its patent in more than 130 countries, allowing generic-makers to copy the drug.

"This addresses any misconception that access to our medicines is limited," the company said.

Christophe Perrin, a TB expert at Doctors Without Borders, called J&J's reversal "a big surprise" because aggressive patent protection was typically a "cornerstone" of pharmaceutical companies' strategy.

Meanwhile, in Colombia, the government declared last month that it would issue a compulsory license for the HIV drug dolutegravir without permission from the drug's patent-holder, Viiv Healthcare. The decision came after more than 120 groups asked the Colombian government to expand access to the WHO-recommended drug.

"This is Colombia taking the reins after the extreme inequity of COVID and challenging a major pharmaceutical to ensure affordable AIDS treatment for its people," said Peter Maybarduk of the Washington advocacy group Public Citizen. He noted that Brazilian activists are pushing their government to make a similar move.

Still, some experts said much more needs to change before poorer countries can produce their own medicines and vaccines.

When the coronavirus pandemic hit, Africa produced fewer than 1% of all vaccines made globally but used more than half of the world's supply, according to Petro Terblanche, managing director of Afrigen Biologics. The company is part of a WHO-backed effort to produce a COVID vaccine using the same mRNA technology as those made by Pfizer and Moderna.

Terblanche estimated about 14 million people died of AIDS in Africa in the late 1990s-2000s, when countries couldn't get the necessary medicines.

Back then, President Nelson Mandela's government in South Africa eventually suspended patents to allow wider access to AIDS drugs. That prompted more than 30 drugmakers to take it to court in 1998, in a case dubbed "Mandela vs. Big Pharma."

Doctors Without Borders described the episode as "a public relations disaster" for the drug companies, which dropped the lawsuit in 2001.

Terblanche said that Africa's past experience during the HIV epidemic has proven instructive.

"It's not acceptable for a listed company to hold intellectual property that stands in the way of saving lives and so, we will see more countries fighting back," she said.

Challenging pharmaceutical companies is just one piece to ensuring Africa has equal access to treatments and vaccines, Terblanche said. More robust health systems are critical.

"If we can't get (vaccines and medicines) to the people who need them, they aren't useful," she said.

Yet some experts pointed out that South Africa's own intellectual property laws still haven't been changed sufficiently and make it too easy for pharmaceutical companies to acquire patents and extend their monopolies.

While many other developing countries allow legal challenges to a patent or a patent extension, South Africa has no clear law that allows it to do that, said Lynette Keneilwe Mabote-Eyde, a health care activist who consults for the nonprofit Treatment Action Group.

The South African department of health didn't respond to a request for comment regarding drug procurement and patents.

Andy Gray, who advises the South African government on essential medicines, said J&J's recent decision to not enforce its patent may have more to do with the drug's limited future earnings than caving to pressure from activists.

"Because bedaquiline is not ever going to sell in huge volumes in high-income countries, it's the sort of product they would love to offload at some stage and perhaps earn a royalty from," said Gray, a senior lecturer in pharmacology at the University of KwaZulu-Natal.

In its annual report on TB released earlier this month, the World Health Organization said there were more than 10 million people sickened by the disease last year and 1.3 million deaths. After COVID-19, tuberculosis is the world's deadliest infectious disease and it is now the top killer of people with HIV. WHO noted only about 2 in 5 people with drug-resistant TB are being treated.

Zolelwa Sifumba, a South African doctor, was diagnosed with drug-resistant TB in 2012 when she was a medical student and endured 18 months of treatment taking about 20 pills every day in addition to daily injections, which left her in "immense pain" and resulted in some hearing loss. Bedaquiline was not rolled out as a standard treatment in South Africa until 2018.

"I wanted to quit (treatment) every single day," she said. Since her recovery, Sifumba has become an advocate for better TB treatment, saying it makes little sense to charge poor countries high prices for essential medicines.

"TB is everywhere but the burden of it is in your lower and middle income countries," she said. "If the lower income countries can't get it (the drug), then what's the point? Who are you making it for?"

___

Cheng reported from London.

___

AP health coverage: https://apnews.com/health

Continue Reading...

Popular

Mark Cuban Reacts to Elon Musk-Donald Trump Feud

The escalating public feud between Elon Musk and President Trump has prompted a response from Mark Cuban.

Gold Just Hit Another Record. This Junior Could Be Next. - Ad

This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.

The Father-Son Duo Revolutionizing Homebuilding - Ad

Paolo and Galiano Tiramani founded BOXABL with a disruptive idea: bring factory efficiency to homebuilding. Today, new homes can roll off their assembly lines in ~4 hours - with 700+ built already. Now, they're prepping for Phase 2, combining modules into larger homes and apartments.

The Next Palantir? Does This Under $5 AI Stock Have The Potential To Rise And Shine

This micro-cap AI stock is being increasingly touted as the next Palantir Technologies Inc. (NASDAQ: PLTR), but some analysts disagree with this framing.

Peter Thiel's Flying Car Dream Nears Reality With Joby Aviation, But Joe Lonsdale Warns FAA 'Must Move Fast' As China Could Overtake US Amid Regulatory Delays

Venture capitalist Joe Lonsdale is sounding the alarm on Chinese competition in the flying car sector while showcasing American innovation through Joby Aviation Inc., as regulatory delays threaten US market leadership in the emerging eVTOL industry.

Why BlackRock is Hoarding 6X More Bitcoin Than Miners Produce - Ad

A Bitcoin supply shock is building. Institutions and ETFs are buying faster than miners can keep up - creating a shortage most investors haven't noticed. If Bitcoin hits $300K, altcoins could explode 1,000%+. We wrote Crypto Revolution to help you prepare.

Cathie Wood Sells Tesla Stock As Chinese Rivals Gain Ground — Ark Dumps Palantir Amid Privacy Concerns

On Monday, Cathie Wood-led Ark Invest sold shares of Tesla and Palantir, amidst competition and data misuse concerns. Ark also made significant trades in other companies, such as eToro and Illumina.

A Better Hedge Than Gold? - Ad

While the whole world is piling into gold as a hedge... White House documents reveal Trump is betting big on a completely under-the-radar resource. This little-known resource is minting 1,600 millionaires every single day... And investors have a rare opportunity to take advantage before everyone else catches on.

Ericsson, Supermicro Partner To Bring 5G-Powered AI To Factories, Retail And Hospitals

Ericsson and Super Micro announce strategic collaboration to accelerate Edge AI deployment. Super Micro stock down 45%, Ericsson up 38% in past year.

Inflation data threatened by government hiring freeze as tariffs loom

WASHINGTON (AP) — The Labor Department has cut back on the inflation data it collects because of the Trump administration's , raising concerns among economists about the quality of the inflation figures just as they are being closely watched for the impact of tariffs.

How To Build a Home in Nearly 4 Hours - Ad

The U.S. is short 2.3M homes, making affordable, efficient housing critical. BOXABL brought assembly lines to construction, building homes in hours, not months. With 700+ built and one of America's largest homebuilders as an investor and partner, they're growing fast.

Federal judge blocks Trump's firing of Consumer Product Safety Commission members

BALTIMORE (AP) — A federal judge has blocked the terminations of three Democratic members of the Consumer Product Safety Commission after they were fired by President Donald Trump in his effort to assert over independent federal agencies.

Shopify Teams Up With Coinbase, Stripe To Roll Out USDC Stablecoin Payments For Merchants

Tobi Lütke, CEO of Shopify Inc. (NASDAQ:SHOP), said Thursday that the firm has partnered with Coinbase Global Inc. (NASDAQ:COIN) to integrate USD Coin (CRYPTO:

Former Zillow Execs Target $1.3T Market - Ad

One co-founded Zillow. The other sold his company to Zillow for $120M. Now they're transforming a $1.3T market via co-ownership. Pacaso's already earned $110M+ in gross profit and reserved the Nasdaq ticker PCSO.

First direct flight from US to Greenland since 2008 lands on Trump's birthday

NUUK, Greenland (AP) — The first direct flight from the U.S. to Greenland by an American airline landed in the capital city of Nuuk on Saturday.

Senate Republicans revise ban on state AI regulations in bid to preserve controversial provision

WASHINGTON (AP) — Senate Republicans have made changes to their party's sweeping tax bill in hopes of preserving a new policy that would prevent states from regulating artificial intelligence for a decade.

Trump's $500B Plan Is Fueling These Monthly Dividends - Ad

Just 24 hours after Trump returned to office, he signed a secretive document tied to a $500 billion income loophole. It's now fueling monthly payouts like $1,125... $1,792... even $4,290 - regardless of market direction. No stock picking. No timing. Just steady, automatic income.

Elon Musk Recently Said 'Yes' To Impeaching Trump And The Odds Of That Happening In 2025 Rose On This Crypto Betting Market

The odds that President Donald Trump would be impeached this year saw a spike on Polymarket after tech mogul Elon Musk backed a call to remove him from office. 

How high will Bitcoin go in 2025? - Ad

A new coin is emerging in the crypto bull market. Investing now could be like buying Bitcoin in 2013. Before it took off. Or scooping up Ethereum in 2017.. before it soared.

Trump-Musk Feud Gets Ugly: ETFs Exposed With Tesla Caught In The Crossfire

ETFs with high exposure to Tesla could be risky due to political tensions between Musk and Trump. TSLA stock plummeted and could impact ETFs.

Cathie Wood Dumps $1.8 Million In Coinbase Stock As Bitcoin Nears $110K All-Time High

On Monday, Cathie Wood-led Ark Invest made a notable move by selling shares of Coinbase Global Inc. (NASDAQ:COIN) across its ETFs.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Palantir CEO Warns US-China AI Race Will Have One Winner, Urges West To Keep Up

PLTR CEO Karp believes US will win AI race with China, expressing concerns about its dangers while acknowledging its benefits. Stock down.

Musk vs. Trump: Tesla Slashes Cybertruck Prices After Feud Heats Up, Here's How Much You Need To Pay for It Now

In the wake of the public disagreement between Elon Musk and President Trump, Tesla has declared significant price reductions for its Cybertruck model.

"Work Is the New Retirement"-Don't Let That Be You - Ad

Social Security's failing. Inflation's rising. And retirees are being forced back to work. That's why I created a new strategy: "AI Royalties." Backed by Trump's $500B plan, it's helping Americans collect up to $4,290/month in second retirement income. My short video explains how.

Apple May Launch New Hardware At WWDC 2025: Mac Pro, HomePad, AirTag 2 Expected

Rumors suggest that Apple's WWDC 2025 may feature surprise hardware announcements, including a new Mac Pro.

Gold Just Hit Another Record. This Junior Could Be Next. - Ad

This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.

Latin America's Hot Stocks: 3 NYSE Picks To Dodge Trade Wars, Mideast Mayhem

Latin American markets, boosted by Brazil's Bovespa & Mexico's IPC, offer diversification and stability amid tariff threats and chaos. NYSE-listed Vale, Ambev, and Cemex are compelling with high yields, low P/E ratios, and resilience to trade tensions and Middle East volatility.

The Father-Son Duo Revolutionizing Homebuilding - Ad

Paolo and Galiano Tiramani founded BOXABL with a disruptive idea: bring factory efficiency to homebuilding. Today, new homes can roll off their assembly lines in ~4 hours - with 700+ built already. Now, they're prepping for Phase 2, combining modules into larger homes and apartments.

Nvidia chief calls AI ‘the greatest equalizer’ — but warns Europe risks falling behind

PARIS (AP) — Will save humanity — or destroy it? Lift up the world’s poorest — or tighten the grip of a tech elite?

Trump pushes a July 4th deadline for big tax bill as senators dig in

WASHINGTON (AP) — wants his of tax breaks and spending cuts on his desk to be signed into law by the Fourth of July, and he's pushing the slow-rolling Senate to make it happen sooner rather than later.

Why BlackRock is Hoarding 6X More Bitcoin Than Miners Produce - Ad

A Bitcoin supply shock is building. Institutions and ETFs are buying faster than miners can keep up - creating a shortage most investors haven't noticed. If Bitcoin hits $300K, altcoins could explode 1,000%+. We wrote Crypto Revolution to help you prepare.

Snack Wrap unwrapped: Here's why McDonald's is bringing back a fan favorite on July 10

If ever doubted it needed to bring back the Snack Wrap, consider this: Nine years after the fast-food powerhouse the item in the U.S., customers have continued to order it .

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service